LichtLab Sequencing - run details
Back to list
Project
*
Choose one...
Evans MDS
H2B - E76K
LeleLab collaboration
Melanoma
NSD2 - E1099K
Other
SETD2 inhibitor
UTX - KDM6A
Assay
*
Choose one...
RNA-Seq
ChIP-Seq
CUT&RUN
ATAC-Seq
scRNA-Seq
CRISPR
Title
*
Organism / cell line
*
ICBR number (if known)
Owner
Notes
RCH-ACV with NSD2 inhibitor/NSD2i (A5782) treatment for 6 days
Samples
Enter sample names, one per row. If possible, use the format COND_SMP, where COND is an experimental condition and SMP is a unique sample name.
Mut-NSD2i-0-Rep1 Mut-NSD2i-1-Rep1 WT-NSD2i-0-Rep1 WT-NSD2i-1-Rep1 Mut-NSD2i-0-Rep2 Mut-NSD2i-1-Rep2 WT-NSD2i-0-Rep2 WT-NSD2i-1-Rep2 Mut-NSD2i-0-Rep3 Mut-NSD2i-1-Rep3 WT-NSD2i-0-Rep3 WT-NSD2i-1-Rep3
Contrasts
Enter contrasts, one per row. A contrast consists of two sample name separated by spaces, as in "Test Control".
MUT-NSD2i-1 MUT-NSD2i-0 WT-NSD2i-1 WT-NSD2i-0 MUT-NSD2i-1 WT-NSD2i-0
Options
ERCC spike-ins
Dmel spike-ins
Ecoli spike-ins
Analyzed
Analysis notes
2023-06-23 15:48:27
Analysis done, results:
https://lichtlab.cancer.ufl.edu/reports/NSD2/NSD_RS_20230622/